Can murine uterine natural killer cells give insights into the pathogenesis of preeclampsia?

Journal of the Society for Gynecologic Investigation

Volumn 7, Issue 1, 2000, Pages 12-20

  Croy, B Anne ^a   Ashkar, Ali A ^a   Minhas, Kanwal ^a   Greenwood, Janice D ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Decidua; Endothelium; Intrauterine growth retardation; Mouse pregnancy; Placenta; Spiral arteries; Vascular modification

Indexed keywords

CD56 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 1; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; GENE CONTROL; GENE MUTATION; LYMPHOCYTE; MORPHOMETRICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW;

ANIMALS; FEMALE; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MICE; PRE-ECLAMPSIA; PREGNANCY; UTERUS;

EID: 0033978393     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(99)00049-0     Document Type: Review

References (77)

1. Stewart I.J. Granulated metrial gland cells in "minor" species. J Reprod Immunol. 40:1998;129-146.
2. Carlyle J.R., Zuniga-Pflucker J.C. Lineage commitment and differentiation of T and natural killer lymphocytes in the fetal mouse. Immunol Rev. 165:1998;63-74.
3. Spits H., Blom B., Jaleco, et al. Early stages in development of human T, natural killer and thymic dendritic cells. Immunol Rev. 165:1998;75-86.
4. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187-376.
5. Kurago Z.B., Lutz C.T., Smith K.D., Colonna M. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated Engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells . J Immunol. 160:1998;1573-1580.
6. Loke Y.W., King A. Human implantation Cell biology and immunology . 1989;108 Cambridge University Press, Cambridge.
7. Searle R.F., Jones R.K., Bulmer J.N. Phenotypic analysis and proliferative responses of human endometrial granulated lymphocytes during the menstrual cycle. Biol Reprod. 60:1999;871-878.
8. Peel S. Granulated metrial gland cells. Adv Anat Embryol Cell Biol. 115:1989;1-112.
9. Pace D., Morrison L., Bulmer J.N. Proliferative activity in endometrial stromal granulocytes throughout the menstrual cycle and early pregnancy. J Clin Pathol. 42:1989;35-39.
10. Chantakru S., Miller C., Croy B.A. Uterus lacks the capability for self-renewal of natural killer cells. Placenta. 20:1999;A16.
11. dim natural killer cell subsets. J Immunol. 161:1998;400-408.
12. Tedder T.F., Steeber D.A., Chen A., Engel P. The selectins Vascular adhesion molecules . FASEB J. 9:1995;866-873.
13. Gudelj L., Deniz G., Rukavina D., Johnson P.M., Christmas S.E. Expression of functional molecules by human CD3- decidual granular leucocyte clones. Immunology. 87:1996;609-615.
14. Gudelj L., Christmas S.E., Laskarin G., Johnson P.M., Podack E.R., Rukavina D. Membrane phenotype and expression of perforin and serine esterases by CD3- peripheral blood and decidual granular lymphocyte-derived clones. Am J Reprod Immunol. 38:1997;162-167.
15. Parr E.L., Parr M.B., Zheng L.M., Young J.D.E. Granulated metrial gland cells originate by local activation of uterine natural killer lymphocytes. Biol Reprod. 44:1991;834-841.
16. Pollack S.B., Linnemeyer P.A. Natural killer cells in the nonpregnant murine uterus. Nat Immun. 7:1996;15:34-15:40.
17. Delgado S.R., McBey B.A., Yamashiro S., Fujita J., Kiso Y., Croy B.A. Accounting for the peripartum loss of natural killer cell-like granulated metrial gland cells from the pregnant mouse uterus. J Leukoc Biol. 59:1996;262-269.
18. Croy B.A., Kiso Y. Granulated metrial gland cells A natural killer cell subset of the pregnant murine uterus . Microsc Res Technol. 25:1993;189-200.
19. Burkhardt J.K., Wiebel F.A., Hester S., Argon Y. The giant organelles in beige and Chediak-Higashi fibroblasts are derived from late endosomes and mature lysosomes. J Exp Med. 178:1993;1845-1856.
20. Luross J., Croy B.A. A study on the relationship between parity and frequency of granulated metrial gland cells. Placenta. 17:1996;521-525.
21. Head J.R. Uterine natural killer cells during pregnancy in rodents. Nat Immun. 15:1996/7;7-21.
22. Wang B, Biron C, She J, et al. A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci USA 1004;91:9402-6.
23. Di Santo J.P., Müller W., Guy-Grand D., Fischer A., Rajewsky D. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ gene. Proc Natl Acad Sci USA. 92:1995;377-381.
24. Colucci F., Soudais C., Rosmaraki E., Vanes L., Tybulewicz V.L., Di Santo J.P. Dissecting NK cell development using a novel alymphoid mouse model Investigating the role of the c-abl proto-oncogene in murine NK cell differentiation . J Immunol. 162:1999;2761-2765.
25. Suzuki H., Duncan G.S., Takimoto H., Mak T.W. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2Rβ chain. J Exp Med. 185:1997;499-505.
26. Taki S., Sato T., Ogasawara K., et al. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 6:1997;673-679.
27. Guimond M.J., Wang B., Croy B.A. Immune competence involving the natural killer cell lineage promotes placental growth. Placenta. 20:1999;441-450.
28. Guimond M.J., Luross J.A., Wang B., Terhorst C., Danial S., Croy B.A. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in Tgε26 mice. Biol Reprod. 56:1997;169-179.
29. Greenwood JE, Di Santo JP, Minhas K, Makita M, Kiso Y, Croy BA. Ultrastructural studies of implantation sites from mice deficient in uterine natural killer cells. Placenta (In press).
30. Croy B.A., Ashkar A.A., Foster R.A., et al. Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy. J Reprod Immunol. 35:1997;111-133.
31. Guimond M.J., Wang B., Croy B.A. Engraftment of NK cells reverses the reproductive deficits in pregnant NK cell and T cell deficient Tgε26 mice. J Exp Med. 187:1998;217-223.
32. Cipolla M., Binder N., Osol G. Myoendometrial versus placental uterine arteries Structural, mechanical, and functional differences in late-pregnant rabbits . Am J Obstet Gynecol. 177:1997;215-221.
33. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-95 and appended Web site.
34. Boehm U., Guethlein L., Klamp T., et al. Two families of GTPases dominate the complex cellular response to IFN-γ J Immunol. 161:1998;6715-6723.
35. Delassus S., Coutinho G.C., Saucier C., Darche S., Kourilsky P. Differential cytokine expression in maternal blood and placenta during murine gestation. J Immunol. 152:1994;2411-2420.
36. bright natural killer cells in the human early pregnancy decidua. Int Immunol. 5:1993;550-563.
37. Platt J.S., Hunt J.S. Interferon-gamma gene expression in cycling and pregnant mouse uterus temporal aspects and cellular localization . J Leukoc Biol. 64:1998;393-400.
38. Lin H., Mosmann T.R., Guilbert L., Tuntipopipat S., Wegmann T.G. 1993. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol. 151:1993;4562-4573.
39. Ashkar A.A., Croy B.A. Interferon-γ contributes to the normalcy of murine pregnancy. Biol Reprod. 61:1999;493-502.
40. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1993;1739-1742.
41. Huang S., Hendriks W., Althage A., et al. Immune response in mice that lack the interferon-gamma receptor. Science. 259:1993;1742-1745.
42. Gupta S., Xia G., Lee S., Pernis A.B. Signaling pathways mediated by the TNF- and cytokine-receptor families target a common cis-element of the IFN regulatory factor 1 promoter. J Immunol. 161:1998;5997-6004.
43. Decker T., Kovarik P., Meinke A. GAS elements A few nucleotides with a major impact on cytokine-induced gene expression . J Interferon Cytokine Res. 17:1997;121-134.
44. Kamijo R., Harada H., Matsuyama T., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
45. Schindler C., Darnell J.E. Transcriptional responses to polypeptide ligands The JAK-STAT pathway . Annu Rev Biochem. 64:1995;621-651.
46. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia An excessive maternal inflammatory response to pregnancy . Am J Obstet Gynecol. 180:1999;499-506.
47. Hayman R., Brockelsby J., Kenny L., Baker P. Preeclampsia The endothelium, circulating factor(s) and vascular endothelial growth factor . J Soc Gynecol Investig. 6:1999;3-10.
48. Hunt J.S., Miller L., Vassmer D., Croy B.A. Expression of the inducible nitric oxide synthase gene in mouse uterine leukocytes and potential relationships with uterine function during pregnancy. Biol Reprod. 57:1997;827-836.
49. Sladek S.M., Kanbourshakir A., Watkins S., Berhgorn K.A., Hoffman G.E., Roberts J.M. Granulated metrial gland cells contain nitric oxide synthases during pregnancy in the rat. Placenta. 19:1998;55-65.
50. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:1995;70-74.
51. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
52. Davis S., Aldrich T.H., Jones P.F., et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87:1996;1161-1169.
53. Folkman J., D'Amore P.A. Blood vessel formation What is its molecular basis? Cell. 87:1996;1153-1155.
54. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:1997;961-990.
55. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
56. Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 277:1997;48-50.
57. Dickson M.C., Martin J.S., Cousins F.M., Kulkarni A.B., Karlsson S., Akhurst R.J. Defective hematopoiesis and vasculogeneisis in transforming growth-factor-beta 1 knockout mice. Development. 121:1995;1845-1854.
58. Hirschi K.K., Rohovsky S.A., D'Amore P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 141:1998;805-814.
59. Antonelli-Orlidge A., Saunders K.B., Smigh S.R., D'Amore P.A. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA. 86:1989;4544-4548.
60. Morello J.P., Plamondon J., Meyrick B., Hoover R., O'Connor-McCourt M.D. Transforming growth factor-β receptor expression on endothelial cells Heterogeneity of type III receptor expression . J Cell Physiol. 165:1995;201-211.
61. Williams M.F. The vascular architecture of the rat uterus as influenced by estrogen and progesterone. Am J Anat. 83:1948;247-307.
62. Taipale J., Saharinen J., Keski-Oja J. Extracellular matrix-associated transforming growth factor-beta Role in cancer cell growth and invasion . Adv Cancer Res. 75:1998;87-134.
63. Mainiero F., Gismondi A., Soriani A., et al. Integrin-mediated Ras-extracellular regulated kinase (ERK) signaling regulated Interferon γ production in human natural killer cells. J Exp Med. 188:1998;1267-1275.
64. Maisonpierre P.C., Suri C., Jones P.F., et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogensis. Science. 277:1997;55-60.
65. Asahara T., Chen D., Takahashi T., et al. Tie-2 receptor ligands, angiopoietin-1 and angiopoeitin-2, modulate VEGF-induced postnatal neovascularization. Circ Res. 83:1998;233-240.
66. 2-macroglobulin gene. Biochemistry. 27:1988;9194-9203.
67. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia An endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
68. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol. 101:1994;669-674.
69. Kingdom J.C., Kaufmann P. Oxygen and placental villous development Origins of fetal hypoxia . Placenta. 18:1997;613-621.
70. Genbacev O., Joslin R., Damsky C.H., Polliotti B.M., Fisher S.J. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest. 97:1996;540-550.
71. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol. 40:1998;102-111.
72. Williams M.A., Farrand A., Mittendorf R., et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol. 149:1999;323-329.
73. Fischer A., Cavazzana-Calvo M., De Saint Basile G., et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol. 15:1997;93-124.
74. Alanen A., Lassila O. Deficient natural killer cell function in preeclampsia. Obstet Gynecol. 60:1982;631-634.
75. Hill J.A., Hsia S., Doran D.M., Bryans C.I. Natural killer cell activity and antibody dependent cell-mediated cytotoxicity in preeclampsia. J Reprod Immunol. 9:1986;205-212.
76. Siklos P., Nemeth-Csoka A., Bartalits L., et al. Decreased killer cell activity in preeclampsia. Gynecol Obstet Invest. 23:1987;84-88.
77. Kaminski K., Wiktor H., Oleszczuk J. Natural cytotoxicity of CD16+ lymphocytes in women with selected states of pregnancy pathology. Ginekol Pol. 66:1995;193-197.